Evelin E. Lara-Molina

Dr. Evelin E. Lara-Molina


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2024 in Analytica Chimica Acta
Verified
Journal Article
Open access
VVVíctor Vállez-Gomis
Víctor Vállez-Gomis
JBJuan L. Benedé
Juan L. Benedé
ELEvelin E. Lara-Molina
Evelin E. Lara-Molina
MLMarina López-Nogueroles
Marina López-Nogueroles
ACAlberto Chisvert
Alberto Chisvert
Bisphenols, particularly bisphenol A (BPA), are the primary monomers used as additives in the manufacturing of many consumer products. The exposure to these compounds is related to endocrine-disrupting and reproductive effects, among others. For this reason, the development of analytical methods for their determination in biological matrixes is needed to monitor the population exposure to these compounds. Their quantification at ovarian level (i.e., follicular fluid) is interesting for the assessment of the bisphenol content to draw conclusions about infertility problems. However, the background does not meet all requirements by focusing mainly on BPA. In this work, a miniaturized stir bar sorptive dispersive microextraction (mSBSDME) approach has been developed for the determination of BPA and eight analogues in follicular fluid. In the proposed method, the sample is previously cleaned-up using a zirconia-based solid-phase extraction cartridge, removing proteins and phospholipids, and then subjected to the mSBSDME for the preconcentration of the analytes. For this purpose, a magnetic covalent organic framework was used as sorbent. A Plackett-Burman design was applied to select the significant variables affecting the mSBSDME. Afterwards, the only significant variable (i.e., sorbent amount) was optimized. Under the optimized conditions, the proposed method was properly validated, and satisfactory analytical parameters in terms of linearity (up to 50 ng mL-1), enrichment factors (8.5-14.3), limits of detection in the low ng mL-1 range, and precision (relative standard deviations below 11.5 %) were obtained. Finally, the method was successfully applied to five samples, detecting BPA and other two analogues. This method expands the potential applicability of the mSBSDME to other low-availability complex matrixes, which would otherwise be difficult to analyze. Moreover, it offers a valuable tool for monitoring the female population's exposure to bisphenols with the final aim of evaluating if infertility problems of women might be associated to the exposure to these highly endocrine disrupting compounds.

1 August 2017 in Current Opinion in Obstetrics and Gynecology
Verified
Journal Article
Closed access
PDF file
JFJason M. Franasiak
Jason M. Franasiak
ELEvelin E. Lara-Molina
Evelin E. Lara-Molina
APAntonio Pellicer
Antonio Pellicer
Purpose of review: Vitamin D deficiency has been associated with a wide range of human disease states and the global epidemic, particularly in reproductive aged women, has led to a focus on this complex hormones role in human reproduction. Indeed vitamin D receptors are found throughout the reproductive tract in the ovary, endometrium, and the placenta. It has roles both in calcium-dependent and independent pathways. However, agreement upon the most appropriate way to assess vitamin D status and ultimately its activity at various sites has proven challenging. Recent findings: Investigators have studied vitamin D's role in assisted reproduction and found successful outcomes are correlated with vitamin D replete status. However, subsequent studies have found mixed results when parsing its role in folliculogenesis and oogenesis versus its impact on embryonic implantation in the endometrium. Correlation was shown in a donor oocyte model which suggests endometrial involvement; however, in a euploid blastocyst transfer model with attention to embryo and endometrial synchrony this was not seen. It may be that the major impact is proximal to blastocyst formation at the site of folliculogenesis as has been shown in a primate model. Taken together, these studies suggest that vitamin D's role may be more sophisticated when it comes to reproductive success. Further, it has become clear that the nonstandard method of determining vitamin D status in the clinical and research settings requires clarification to ensure more comparable data in future studies. Summary: Vitamin D has clear roles in human health and disease, and its impact on human reproduction seems promising but requires clarification. With new techniques for assessing its status in patients and its impact at end organs as well as evolving theories regarding its potential to influence folliculogenesis, endometrial receptivity, and ovarian aging, we will soon gain additional clarity and hope to be able to impact reproductive success in a positive way.

7 September 2025 in medRxiv
Verified
Preprint
Open access
PDF file
COChristian Simon Ottolini
Christian Simon Ottolini
FMFrancesca Mulas
Francesca Mulas
RCRebecca Cavagnola
Rebecca Cavagnola
EPElvezia Maria Paraboschi
Elvezia Maria Paraboschi
LPLudovica Picchetta
Ludovica Picchetta
ACAntonio Capalbo
Antonio Capalbo
Background: In vitro fertilization (IVF) outcomes remain variable and difficult to predict, even in individuals without diagnosed infertility. This uncertainty complicates clinical decision-making and impedes the identification of biological factors that underlie IVF success or failure. A major barrier to progress is the absence of standardized criteria to distinguish true biological inefficiencies from random variation or technical noise in IVF procedures. Objective: To develop a robust statistical framework for defining IVF under- and overperformance in a fertile population, enabling precise phenotyping of IVF inefficiencies and laying the foundation for future genomic and mechanistic studies. Methods: We conducted the largest retrospective cohort analysis to date of IVF outcomes in 114.237 oocyte donation cycles, from 32.492 rigorously screened donors who underwent 84.228 stimulation cycles. IVF performance was evaluated across four developmental stages: oocyte maturation, fertilization, blastocyst formation, and preimplantation development efficiency. Donors were classified as statistical under- or overperformers using a combination of binomial testing and mixed-effects logistic regression models, adjusting for identified confounders. Reproducibility of performance classifications was assessed through multi-cycle consistency analyses and supervised predictive modelling. Results: Despite stringent fertility screening, 0.9% to 2.1% of donors were identified as statistically underperformers in individual developmental metrics, with similar proportions observed for overperformers. Minimal overlap between donors falling into significant categories across different developmental metrics supported the interpretation of IVF performance as comprising biologically distinct endophenotypes. Underperformance was reproducible across multiple cycles in a subset of donors (P < 0.001), indicating a likely biological basis rather than random or procedural variability. Logistic regression models demonstrated modest predictive ability for future outlier status (AUC > 0.61 and < 0.71), further supporting the presence of stable, donor-specific traits. Interestingly, comparison of donor clinical variables revealed a possibly clinically meaningful difference in the distribution of donors that had a documented live birth prior to donation between performance groups for all developmental metrics, indicating a potential association with proven fertility and better IVF outcomes. Finally, 109 donors across performance groups were surveyed, revealing no identifiable differences in natural fertility outcomes, further reinforcing that IVF inefficiency does not necessarily reflect underlying infertility. Conclusion: This unprecedented and methodologically rigorous analysis demonstrates that statistically significant deviations in IVF outcomes can occur even among presumed fertile donors. These findings challenge the assumption that poor IVF outcomes are inherently indicative of infertility and support a shift toward defining IVF failure through biological, rather than purely clinical, criteria. Our standardized phenotyping framework offers a powerful tool for identifying the molecular and genetic contributors to IVF inefficiency and for advancing personalized reproductive medicine.

2 December 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
ELEvelin E. Lara-Molina
Evelin E. Lara-Molina
JFJason M. Franasiak
Jason M. Franasiak
ADAlmudena Devesa-Peiro
Almudena Devesa-Peiro
MLMarina Lopez-Nogueroles
Marina Lopez-Nogueroles
AVAlberto Vázquez
Alberto Vázquez
PDPatricia Diaz-Gimeno
Patricia Diaz-Gimeno
Background/Objectives: One of the main reasons for discrepancies in the role of vitamin D in ART could be the measurement of the conventional biomarker 25(OH)D3. It is known that this value is affected by multiple factors, such as tissue origin, assay variability, classification criteria, and potential storage-related degradation. In this study, we investigate 24,25(OH)2D3 as a new biomarker to improve vitamin D assessment in women’s reproductive health, particularly regarding oocyte development. Methods: A prospective cohort study including 35 oocyte donors undergoing controlled ovarian stimulation, who were recruited between October and November 2017, was conducted. Vitamin D metabolites were measured at the baseline and after seven months of storage at −80 °C. Paired serum and pooled follicular fluid (FF) samples were collected at oocyte retrieval. 25(OH)D3 and 24,25(OH)2D3 were quantified by ultra-performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS). Statistical analyses included paired tests (serum vs. FF; baseline vs. stored) and Pearson’s correlations (two-sided α = 0.05). Results: At the baseline, the mean serum 25(OH)D3 concentration was 91.56 ± 39.01 nmol/L and the mean FF concentration was 58.13 ± 19.55 nmol/L (p < 0.0001). Serum 24,25(OH)2D3 averaged 15.62 ± 10.99 nmol/L, compared with 11.26 ± 6.09 nmol/L in FF (p = 0.004). In both fluids, 25(OH)D3 and 24,25(OH)2D3 were strongly correlated (serum R2 = 0.92; FF R2 = 0.91). Across fluids, the serum–FF correlation was stronger for 24,25(OH)2D3 (R2 = 0.77, p <0.0001) than for 25(OH)D3 (R2 = 0.69, p < 0.0001). After seven months of storage, 25(OH)D3 concentrations decreased significantly (serum −32%; FF −38%; both p < 0.0001), whereas 24,25(OH)2D3 levels remained stable (serum p = 0.24; FF p = 0.36). Conclusions: Serum 24,25(OH)2D3 is a more reliable and minimally invasive biomarker for assessing ovarian vitamin D status than the current gold standard, 25(OH)D3. Incorporating this metabolite into research studies and storage quality control may improve the reliability of retrospective analyses based on cryopreserved material, contributing to a better understanding of the role of vitamin D in human reproduction.